2-[5-[4-amino-2-(methoxymethyl)phenoxy]pentyl]isoindole-1,3-dione

Names

[ CAS No. ]:
5896-96-8

[ Name ]:
2-[5-[4-amino-2-(methoxymethyl)phenoxy]pentyl]isoindole-1,3-dione

[Synonym ]:
2-{5-[4-amino-2-(methoxymethyl)phenoxy]pentyl}-1H-isoindole-1,3(2H)-dione
M &B 5999

Chemical & Physical Properties

[ Molecular Formula ]:
C21H24N2O4

[ Molecular Weight ]:
368.42600

[ Exact Mass ]:
368.17400

[ PSA ]:
81.86000

[ LogP ]:
3.77960

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TI3945000
CHEMICAL NAME :
Phthalimide, N-(5-(4-amino-alpha-methoxy-o-tolyloxy)pentyl)-
CAS REGISTRY NUMBER :
5896-96-8
BEILSTEIN REFERENCE NO. :
1552632
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C21-H24-N2-O4
MOLECULAR WEIGHT :
368.47

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 29,248,1967

Related Compounds

  • 3-Methyl-7-[3-[3-methyl-8-(3-methylpiperidin-1-yl)-2,6-dioxo-4,5-dihydropurin-7-yl]propyl]-8-(3-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione
  • 5-[2-(4-chlorophenyl)-2-hydroxyethyl]-2-(2-methylphenyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one
  • N-cyclopentyl-2-{5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}acetamide
  • N-(4-chlorophenyl)-2-{5-oxo-2-propyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}acetamide
  • CID 156590842
  • CID 156591013
  • ethyl 3-oxo-3-[(3R)-pyrrolidin-3-yl]propanoate
  • Tert-butyl (3-iodocyclobutyl)(methyl)carbamate
  • Mal-beta-Ala-PEG(4)-Val-Cit-PAB-PNP
  • 4-(fluoromethyl)-1-(1H-imidazole-4-sulfonyl)piperidine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.